ABBN.SW: $86.50 ▲ 0.40 (0.46%)ASML.AS: $1,578.40 ▲ 17.60 (1.13%)ENR.DE: $160.60 ▼ -1.90 (-1.17%)GLEN.L: $532.40 ▼ -2.90 (-0.54%)IFX.DE: $81.31 ▲ 0.75 (0.93%)NOKIA.HE: $12.36 ▲ 0.36 (3.00%)RIO.L: $7,258.00 ▼ -6.00 (-0.08%)AMD: $519.85 ▼ -31.78 (-5.76%)INTC: $132.28 ▼ -8.66 (-6.14%)MU: $1,051.77 ▼ -159.61 (-13.18%)WDC: $670.75 ▼ -61.87 (-8.45%)AAPL: $294.30 ▼ -2.71 (-0.91%)AMZN: $234.11 ▲ 1.32 (0.57%)NVDA: $200.04 ▼ -8.61 (-4.13%)AMAT: $585.88 ▼ -54.30 (-8.48%)CIEN: $459.85 ▼ -0.48 (-0.10%)STX: $1,038.59 ▼ -55.45 (-5.07%)

Company Details

Check-Cap Ltd.

CHEK - NASDAQ

Identifiants & Marche

Ticker CHEK
ISIN IL0011336851
CIK 0001610590
Bourse NASDAQ
Devise USD

Classification

Secteur Healthcare

Entreprise

Pays IL
Siege N/A
Fondee N/A
Site Web Lien

Description

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.